Cargando…
Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies
Over the past two decades, aspirin has emerged as a promising chemoprotective agent to prevent colorectal cancer (CRC). In 2016, the mounting evidence supporting its chemoprotective effect, from both basic science and clinical research, led the US Preventive Services Task Force to recommend regular...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895806/ https://www.ncbi.nlm.nih.gov/pubmed/31653027 http://dx.doi.org/10.3390/cancers11111639 |